Skip to content
#protein folding Open access

Proteomic profiling of experimental acute alcohol intoxication reveals FGF21 as a specific ethanol-induced hormone

Oct 2026 · bioRxiv · 0 citations · 2 references
Biology

TL;DR

This study highlights a unique proteomic response to acute alcohol ingestion and supports further exploration of FGF21 mimetics as potential treatments for alcohol-related disorders.

Abstract

Background The effects of acute alcohol intoxication on the human plasma proteome are still largely unexplored. Gaining insights into this relationship could identify factors that are influenced by and influence alcohol consumption. Fibroblast Growth Factor 21 (FGF21), a hormone produced by the liver and associated with alcohol preferences, is currently undergoing Phase 2 clinical trials for metabolic dysfunction and alcohol-related liver disease. We hypothesized that FGF21 is a key endocrine responsive hormone to alcohol in humans. Methods In a post hoc analysis, we evaluated the effects of five standard units of alcoholic beverages on the plasma proteome in 12 healthy Caucasian men. Participants, fasting for 10 hours, received 0.7 g of alcohol per kg of body weight via gastric infusion, with blood samples collected before and after consumption. Results The proteomic response to this level of alcohol intoxication was highly specific. Of 1,462 proteins measured, only 11 changed significantly and FGF21 exhibited by far the largest increase (10.5-fold). Conclusion This study highlights a unique proteomic response to acute alcohol ingestion and supports further exploration of FGF21 mimetics as potential treatments for alcohol-related disorders.

Read PDF

Similar papers

Open access Oct 2026

Effects of chronic alcohol consumption on gene expression in the rat left ventricle: a transcriptomic analysis

Objective Chronic alcohol consumption is one of the leading causes of dilated cardiomyopathy. Alcohol-associated cardiomyopathy (ACM) is characterized by impaired cardiac function and ventricular dilation in individuals with a history of long-term alcohol consumption. Alcohol exerts adverse effects on the myocardium vi...

Wei-Lun Ai, Carol A. Casey, K. Rasineni et al. · 0 citations
Open access Sep 2026

Identification of alcohol use disorder-associated and ethanol-responsive proteins and candidate biomarkers using human cortical organoids

Genome-wide association studies of alcohol use disorder (AUD) have identified >100 loci, yet the functional impact and the downstream molecular mechanisms are not well understood. As functional effectors of genes, proteins provide direct insight into disease mechanisms. However, most proteomic alterations in postmortem...

Xin-Di Li, Andrew J. Boreland, Arpana Agrawal et al. · 0 citations
Review Open access Sep 2026

Alcohol consumption: from biochemistry to behavior, health, and beyond

Alcohol metabolism is a multi-step biochemical process driven primarily by hepatic oxidation of ethanol to acetaldehyde and then to acetate. Although this pathway protects the body from prolonged ethanol exposure, transient acetaldehyde accumulation generates substantial toxicity, and chronic alcohol intake activates a...

Evgeny Pechkovsky, B. Kershengoltz, Valentin Vlassov et al. · 0 citations
Open access Oct 2026

Modulation of Hepatic Glutamate Transporters by MC-100093 in Male and Female Alcohol-Preferring Rats Exposed to Ethanol

Background/Objective: Prolonged ethanol use can induce behavioral and physiological alterations and impair the liver’s capacity to metabolize ethanol, leading to hepatocyte injury. The spectrum of this disease ranges from fat accumulation to severe liver damage, including alcohol-related hepatitis and cirrhosis. MC-100...

A. Alotaibi, K. K. Bhowmik, Virender Kumar et al. · 0 citations
Open access Sep 2026

Screening for medicine and food homologous ingredients targeting ALDH2 to alleviate acute ethanol-induced liver injury

Background Alcoholic liver disease (ALD) is a major global health burden with limited therapeutic options. Aldehyde dehydrogenase 2 (ALDH2) plays a critical role in alcohol metabolism, and ALDH2 deficiency exacerbates alcohol-induced hepatic injury. Aim This study aimed to identify and validate natural ALDH2 activators...

Yuan Lu, Zi-Bin Li, Pan Gao et al. · 0 citations
Open access Oct 2026

Genetic Modulation of ALT Leads to Underestimation of Liver Injury in Male ALDH2*2 Drinkers.

BACKGROUND & AIMS Serum alanine aminotransferase (ALT) is commonly used to detect hepatocellular injury. However, genetic and metabolic factors may modulate ALT levels. We focused on the potential impact of an in-activating mutation in aldehyde dehydrogenase 2 (ALDH2*2, rs671) polymorphism, prevalent among East Asians,...

Takuya Seike, Yi-Hsun Chen, Wei-Chung Chen et al. · 0 citations

Related blog posts

Google DeepMind Blog Sep 30, 2026

Introducing SynthID Bio

Proof of concept for watermarking AI-generated proteins while preserving biological function.

MIT News · Artificial Intelligence Aug 27, 2026

Looking beyond natural sequences

A new machine-learning framework aims to improve the success rate of computational protein design while moving away from results that reproduce sequences found in nature.

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.